MC38-hCD47/hCLDN18.2/hHER3
品系基本信息
*使用本品系发表的文献需注明: MC38-hCD47/hCLDN18.2/hHER3 cell line (Cat. NO. NMC-230043) was purchased from Shanghai Model Organisms Center, Inc..
验证数据
Figure 1. The expression of hCD24 , hCLAUDIN18.2 and hHER3 in MC38-hCD47/hCLAUDIN18.2/hHER3 cell line
Figure 2. Tumor growth curve of MC38-hCD47/hCLAUDIN18.2/hHER3 syngeneic model
Figure 3. Body weight change of MC38-hCD47/hCLAUDIN18.2/hHER3 syngeneic model
Figure 4. The expression of hCD47 , hCLAUDIN18.2 and hHER3 in humanized modified tumors by FACS
你也可能感兴趣
Tamoxifen诱导Cre-ERT2小鼠 使用指南
Cre-ERT2在无Tamoxifen诱导的情况下，在细胞质内处于无活性状态；当Tamoxifen诱导后，Tamoxifen的代谢产物4-OHT（雌激素类似物）与ERT结合，可使Cre-ERT2进核发挥Cre重组酶活性。
查看
